TEL : 02-792-1486 / FAX : 02-792-1410 / E-mail : cancer@kams.or.kr
Updated as of Fab-17, 2020
| Opening Remarks | 09:00-09:10 | |
| 1. | Promise and challenges in cell-based immunotherapy | 09:10-10:50 |
| 1) | NK cell immunotherapy in pancreatic cancer | |
| 이경미 (고려의대) | ||
| 2) | Reneration of cytotoxic T lymphocytes from pluripotent stem cells: Development of "off-the-shelf T cells" for cancer immunotherapy |
|
| Hiroshi Kawamoto (Kyoto University) | ||
| 3) | T-cell immunotherapy through engineering of TCR microclusters | |
| 전창덕 (광주과학기술원) | ||
| 4) | Discovery of a novel splenic subset of dendritic cells and harnessing their potential in immunotherapies | |
| 박채규 (연세의대) | ||
| Coffee Break | 10:50-11:10 | |
| 2. | Quest for cancer vaccine: New development and application | 11:10-12:25 |
| 1) | Therapeutic cancer vaccines | |
| 강태흥 (건국의대) | ||
| 2) | DC vaccine targeting neoantigens | |
| Kazuhiro Kakimi (The University of Tokyo Hospital, Japan) | ||
| 3) | The potential application of exosome inhibitor to improve immuno-oncology therapy | |
| 백문창 (경북의대) | ||
| Luncheon Symposium (Presented by MSD) | 12:25-13:25 | |
| Redefining survival with IO-TKI strategy in RCC | ||
| 김인호 (가톨릭의대) | ||
| 3. | Update on clinical immuno-oncology | 13:40-15:10 |
| 1) | Insights for biology-based combinations to tackle advanced urologic cancer | |
| 김찬 (차의대) | ||
| 2) | Neoadjuvant/Adjuvant immunotherapy in early lung cancer and breast cancer | |
| 안희경 (가천의대) | ||
| 3) | Peripheral blood biomarker related to immune check point inihibitor in non-small cell lung cancer | |
| 안명주 (성균관의대) | ||
| Coffee Break | 15:10-15:30 | |
| 4. | Combination of radiation and immunotherapy | 15:30-17:00 |
| 1) | Novel radiotherapy and immunotherapy approaches for oligometastatic cancer | |
| 장지석 (연세의대) | ||
| 2) | Exploring signals of synergy in clinical practice | |
| 신상준 (연세의대) | ||
| 3) | SART vs. CFRT in inducing the abscopal effect | |
| 박세광 (인제의대) | ||
| Closing Remarks | 17:00-17:05 | |